Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.6342
+0.0109 (1.75%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Unicycive Therapeutics stock have an average target of 5.50, with a low estimate of 3.00 and a high estimate of 7.50. The average target predicts an increase of 767.23% from the current stock price of 0.63.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Unicycive Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Buy | 3 | 3 | 3 | 3 | 3 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +846.07% | Apr 21, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7.5 | Strong Buy | Reiterates | $7.5 | +1,082.59% | Apr 11, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $7.5 | Strong Buy | Maintains | $4 → $7.5 | +1,082.59% | Apr 1, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +530.72% | Jan 29, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 | Strong Buy | Maintains | $4 | +530.72% | Jan 8, 2025 |
Financial Forecast
Revenue This Year
21.15M
Revenue Next Year
375.78M
from 21.15M
Increased by 1,677.16%
EPS This Year
-0.28
from -0.56
EPS Next Year
0.97
from -0.28
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 45.7M | 522.5M | 1.2B | ||
Avg | 21.1M | 375.8M | 503.0M | ||
Low | 4.1M | 234.4M | 163.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | 2,371.2% | 218.0% | ||
Avg | - | 1,677.2% | 33.9% | ||
Low | - | 1,008.5% | -56.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.04 | 1.72 | 3.85 | ||
Avg | -0.28 | 0.97 | 2.01 | ||
Low | -0.42 | 0.43 | 0.26 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | 297.7% | ||
Avg | - | - | 107.7% | ||
Low | - | - | -72.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.